Cardiac Amyloidosis
📧 Sign up to get email alerts when something new happens for Cardiac Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-16Clinical Trial Results: Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy [Phase 4]
Phase 4 trial results on cardiac uptake of 18F Florbetapir in patients undergoing chemotherapy for cardiac amyloidosis. The study is termina…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis [Phase 3]
Phase 3 trial evaluating [18F]Florbetaben PET for diagnosing Cardiac AL Amyloidosis has been completed.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis [NA]
A completed study evaluating novel imaging tools in newly diagnosed cardiac AL amyloidosis patients.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis
Completed clinical trial evaluating cardiac magnetic resonance T1 mapping for diagnosing cardiac amyloidosis.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis [Phase 3]
A Phase 3 clinical trial evaluating molecular imaging of myocardial fibrosis in cardiac amyloidosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis [NA]
A completed clinical trial evaluating an artificial intelligence–enhanced ECG method for detecting cardiac amyloidosis.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis [NA]
This clinical trial update reports an observed increase in the lower-rate pacing setting in patients with transthyretin amyloid cardiomyopat…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Study of Olfactory Disorders in Patients With Cardiac Amyloidosis [NA]
A completed clinical trial conducted by Assistance Publique - Hôpitaux de Paris studied olfactory disorders in patients with cardiac amyloid…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
A completed clinical trial evaluating arrhythmia burden in patients with cardiac amyloidosis using implantable loop recorders to monitor rhy…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis [Phase 3]
A Phase 3 clinical trial evaluating I-124 EVuzamitide for cardiac amyloidosis is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Cardiac Amyloidosis Discovery Trial [NA]
The Cardiac Amyloidosis Discovery Trial (NCT06469372) has completed and posted its results on 2025-12-04.
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Assessment of 18F-Florbetaben Whole-body PET for the Detection of Cardiac and Extracardiac Sites of Amyloid Deposits [NA]
Completed clinical trial assessing 18F-Florbetaben whole-body PET for detecting cardiac and extracardiac amyloid deposits.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT [EARLY_Phase 1]
An early-phase trial evaluating molecular imaging with PET/CT to understand the mechanism of cardiotoxicity in patients with light-chain (AL…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Cardiac Amyloidosis Prevalence and Outcome in Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Implantation [NA]
This completed study evaluated the prevalence of cardiac amyloidosis in patients with aortic stenosis undergoing transcatheter aortic valve …
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Screening Algorithm for Early Detection of Occult Cardiac Amyloidosis
The trial update reports that a study evaluating a screening algorithm for early detection of occult cardiac amyloidosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Cardiac Amyloidosis in Spinal Stenosis: the CASS-study
The CASS-study exploring cardiac amyloidosis in patients with spinal stenosis is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: PET/MR Imaging In Patients With Cardiac Amyloidosis
The PET/MR imaging study in patients with cardiac amyloidosis (NCT03626584) has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy [Phase 4]
Phase 4 trial update on cardiac uptake of 18F Florbetapir in patients undergoing chemotherapy for cardiac amyloidosis.
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography [Phase 4]
Phase 4 pilot study evaluating F-18 florbetapir PET imaging for cardiac amyloidosis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis [Phase 4]
Phase 4 trial investigating F-18 Florbetapir for early detection of Cardiac Amyloidosis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis [Phase 2]
Phase 2 trial evaluating Epigallocatechin gallate (EGCG) for cardiac AL amyloidosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose) [NA]
A completed clinical trial (TEAM Amylose) investigated the frequency of cardiac amyloidosis in Caribbean patients with left ventricular hype…
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL) [Phase 2]
This update notes the completion of a Phase 2 trial evaluating epigallocatechin-3-gallate (EGCG) for cardiac involvement in light chain (AL)…
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis
A completed observational trial (DISCOVERY) evaluated the prevalence of transthyretin (TTR) mutations in subjects suspected of having cardia…